iwCLL Program Committee
iwCLL Program Committee
Jennifer R. Brown, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts, United States
Florence Cymbalista, MD, PhD
Avicenne Hospital
Bobigny, France
Matthew Davids, MD, MMSc
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Sylvia Deaglio, MD, PhD
University of Turin
Turin, Italy
Barbara Eichhorst, MD
University of Cologne
Cologne, Germany
Michael Hallek, MD, PhD
University of Cologne
Cologne, Germany
Peter Hillmen, MB ChB, PhD
The Leeds Teaching Hospitals
St. James’s University
Leeds, United Kingdom
Arnon Kater, MD, PhD
Amsterdam University Medical Centers
Amsterdam, Netherlands
Stephen Mulligan, MBBS, PhD
Royal North Shore Hospital
Laverty Pathology
Sydney, Australia
Thomas J. Kipps, MD
University of California San Diego
La Jolla, California, United States
Susan O’Brien, MD
University of California, Irvine
Orange, California, United States
Christopher Oakes, MD, PhD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio, United States
Tadeusz Robak, MD, PhD
Medical University of Lodz
Lodz, Poland
Anna Schuh, MD, PhD
University of Oxford
Oxford, United Kingdom
John Seymour, MBBS, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia
William Wierda, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas, United States
Adrian Wiestner, MD, PhD
National Institutes of Health (NIH)
Bethesda, Maryland, United States
Jennifer Woyach, MD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio, United States
Catherine Wu, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States